| Literature DB >> 32733588 |
Denis Okello1,2,3, Jun Lee1,3, Youngmin Kang1,3.
Abstract
Inflammatory diseases are major health concerns affecting millions of people worldwide. Aspilia africana has been used for centuries by many African communities in the treatment of a wide range of health conditions, including inflammatory diseases, osteoporosis, rheumatic pains, and wounds. Analysis of the phytochemical composition of A. africana indicated that the plant is rich in a broad range of secondary metabolites, including flavonoids, alkaloids, tannins, saponins, terpenoids, sterols, phenolic compounds, and glycosides. This explains the efficacy of the plant in treating inflammation-related diseases, as well as several other health conditions affecting different African communities. The mechanisms of action of the anti-inflammatory phytochemical compounds in A. africana include inhibition of a number of physiological processes involved in the inflammatory process and synthesis or action of proinflammatory enzymes. The phytochemicals enhance anti-inflammatory biological responses such as inhibition of a number of chemical mediators including histamine, prostanoids and kinins, 5-lipoxygenase. and cyclooxygenase and activation of phosphodiesterase and transcriptase. Currently used anti-inflammatory medications are associated with several disadvantages such as drug toxicity and iatrogenic reactions, thereby complicating the treatment process. The adverse effects related to the use of these conventional synthetic drugs have been the driving force behind consideration of natural remedies, and efforts are being made toward the development of anti-inflammatory agents based on natural extracts. A. africana is rich in secondary metabolites, and its use as a traditional medicine for treating inflammatory diseases has been validated through in vitro and in vivo studies. Therefore, the plant could be further explored for potential development of novel anti-inflammatory therapeutics.Entities:
Year: 2020 PMID: 32733588 PMCID: PMC7321516 DOI: 10.1155/2020/8091047
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Molecular structures and names of different chemical compounds present in A. africana [9, 11, 12].
Profile of phytochemicals in different parts of A. africana.
| Class of compound | Plant part | Type of extract | Status | Reference |
|---|---|---|---|---|
| Saponins | Stem | Ethanol (50%) | +++ | [ |
| Flowers | Dry crude | +++ | [ | |
|
| ||||
| Tannins | Stem | Ethanol (50%) | +++ | [ |
| Flowers | Aqueous | ++ | [ | |
|
| ||||
| Flavonoids | Stem | Ethanol (50%) | ++ | [ |
| Flowers | Aqueous | +++ | [ | |
|
| ||||
| Alkaloid | Leaves | Aqueous | ++ | [ |
| Flowers | Dry crude | +++ | [ | |
|
| ||||
| Terpenoids | Leaves | Aqueous | +++ | [ |
| Flowers | Chloroform | + | [ | |
|
| ||||
| Steroids | Leaves | Aqueous | + | [ |
| Flowers | Dry crude | ++ | [ | |
|
| ||||
| Phenolics | Leaves | Aqueous | ++ | [ |
| Flowers | Aqueous | + | [ | |
|
| ||||
| Cardiac glycosides | Stem | Ethanol (50%) | +++ | [ |
| Flowers | Aqueous | + | [ | |
|
| ||||
| Anthraquinones | Stem | Ethanol (50%) | − | [ |
| Flowers | Dry crude | +++ | [ | |
|
| ||||
| Anthocyanins | Leaves | No data | ||
| Flowers | Aqueous | − | [ | |
|
| ||||
| Carotenoids | Leaves | No data | ||
| Flowers | Aqueous | +++ | [ | |
|
| ||||
| Phlobatannins | Leaves | Chloroform | + | [ |
| Flowers | Dry crude | + | [ | |
Key: +++ = abundantly present; ++ = moderately present; + = trace amount; − = absent.
Selected key individual phytochemical compounds in A. africana with anti-inflammatory activities and their mechanisms of action.
| Name of compound | Class of compounds | Chemical structure | Mechanism of anti-inflammatory action | References |
|---|---|---|---|---|
|
| Terpenoid |
| Suppression of MAPKs and NF- | [ |
| Linolenic acid | Fatty acid |
| Downregulation of inflammatory iNOS, COX-2, and TNF- | [ |
| Phytol | Diterpene |
| Inhibition of proinflammatory mediators and reduces migration of neutrophil and oxidative stress | [ |
| Carene | Monoterpene |
| Inhibition of processes involving prostaglandins or their synthesis | [ |
|
| Sesquiterpene |
| Inhibition of COX-2 | [ |
| Germacrene D | Sesquiterpene |
| Suppression of synthesis of both TNF- | [ |
Figure 2Botanical features of A. africana plant. (a) Plants growing in the wild, (b) stem characteristics and leaf arrangement, (c) features of lower leaf surface, (d) features of upper leaf surface, and (e) inflorescence.
Figure 3Tropical African countries with wide distribution of A. africana (modified from Komakech et al. [2].